Detalles de la búsqueda
1.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462870
2.
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.
Future Oncol
; 18(23): 2593-2604, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722877
3.
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.
J Transl Med
; 17(1): 376, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31730009
4.
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient.
Anticancer Drugs
; 28(5): 551-556, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28296649
5.
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX.
Anticancer Drugs
; 28(3): 322-326, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27845948
6.
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs.
Tumori
; : 3008916241246659, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38623748
7.
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy.
J Exp Clin Cancer Res
; 43(1): 6, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38163906
8.
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.
Tumori
; : 3008916241229287, 2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372045
9.
Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations.
Clin Lung Cancer
; 24(7): 631-640.e2, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37775370
10.
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials.
Crit Rev Oncol Hematol
; 192: 104190, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37871779
11.
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors.
Lung Cancer
; 186: 107417, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37918061
12.
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines.
J Thorac Oncol
; 18(8): 1070-1081, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37094664
13.
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis.
J Immunother Cancer
; 11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286305
14.
Systemic lupus erythematosus reactivation after chemoimmunotherapy in preexisting autoimmune disease.
Tumori
; 108(6): 609-614, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34989254
15.
Paraneoplastic neurological syndromes in patients affected by SCLC: a case series.
Tumori
; 108(6): NP11-NP14, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260015
16.
Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation.
Front Oncol
; 12: 902967, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35756673
17.
Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
Front Immunol
; 13: 987639, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203609
18.
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(7): e489-e499, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35948460
19.
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.
Clin Lung Cancer
; 23(1): e17-e28, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34334296
20.
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.
Cancers (Basel)
; 14(2)2022 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053597